Health ❯ Healthcare ❯ Oncology

Hematologic Malignancies

Blastic Plasmacytoid Dendritic Cell Neoplasm T-Cell Lymphoblastic Lymphoma T-cell Lymphoma B-cell Lymphoma Chimeric Antigen Receptor T-cell Therapy Myelodysplastic Syndromes Small Lymphocytic Lymphoma Diffuse Large B-Cell Lymphoma Chronic Lymphocytic Leukemia T-cell and NK-cell Lymphomas BPDCN

3 ARTICLES

2mo ago

FDA Approves Decnupaz for Rare Blood Cancer

The approval gives adults with blastic plasmacytoid dendritic cell neoplasm a second CD123‑targeted treatment backed by CADENZA response data, with a boxed warning for serious liver toxicity.

5 ARTICLES

8mo ago

FDA Grants Full Approval to Jaypirca for Relapsed CLL/SLL After Covalent BTK Therapy

3 ARTICLES

last yr.

Pivekimab Sunirine Shows 85% Response Rate in BPDCN Trial

9 ARTICLES

last yr.

Next-Generation CAR-T Therapies Deliver Remission in T-Cell Cancers and Extend Survival in Gastric and Brain Tumors